SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-24-068024
Filing Date
2024-03-14
Accepted
2024-03-14 17:15:43
Documents
5
Effectiveness Date
2024-03-14

Document Format Files

Seq Description Document Type Size
1 S-8 d797770ds8.htm S-8 66207
2 EX-5.1 d797770dex51.htm EX-5.1 7367
3 EX-23.1 d797770dex231.htm EX-23.1 1404
4 EX-FILING FEES d797770dexfilingfees.htm EX-FILING FEES 23372
5 GRAPHIC g797770dsp10.jpg GRAPHIC 14314
  Complete submission text file 0001193125-24-068024.txt   119275
Mailing Address 6200 LOOKOUT ROAD BOULDER CO 80301
Business Address 6200 LOOKOUT ROAD BOULDER CO 80301 720-647-8519
Enliven Therapeutics, Inc. (Filer) CIK: 0001672619 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-277949 | Film No.: 24751282
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)